Pontine Glioma – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Pontine Glioma – Drugs In Development, 2024 report and make more profitable business decisions.
Pontine gliomas are highly aggressive and difficult to treat brain tumors found at the base of the brain. One of the most common types is diffuse intrinsic pontine glioma (DIPG). DIPG affects the pons portion of the brainstem, rendering nervous system function impossible. Symptoms include double vision, inability to close the eyelids completely, drooping of one side of the face, and difficulty chewing and swallowing.
The Pontine Glioma drugs in development market research report provide comprehensive information on the therapeutics under development for Pontine Glioma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pontine Glioma and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Pontine Glioma | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 66 molecules, with 52 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Pontine Glioma therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Pontine Glioma pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Pontine Glioma treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Accendatech Co LtdAminex Therapeutics Inc
Ann & Robert H Lurie Children’s Hospital of Chicago
Bayer AG
Beijing zhikangbo Medical Oncology Research Co Ltd
Bellicum Pharmaceuticals Inc
Betta Pharmaceuticals Co Ltd
Bexion Pharmaceuticals Inc
Biodexa Pharmaceuticals PLC
BioMarin Pharmaceutical Inc
Bionaut Labs Inc
Biotech Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Capital Medical University
Cellectar Biosciences Inc
Chimerix Inc
Cold Spring Harbor Laboratory
DNAtrix Inc
Eisai Co Ltd
Eli Lilly and Co
F. Hoffmann-La Roche Ltd
Flag Therapeutics Inc
Fundacio Sant Joan de Deu
Gate2Brain SL
ImmunityBio Inc
Immunomic Therapeutics Inc
Incuron
Karyopharm Therapeutics Inc
Kazia Therapeutics Ltd
Kite Pharma Inc
Lumos Pharma Inc
M4K Pharma Inc
MAIA Biotechnology Inc
Mana Therapeutics Inc
Medicenna Therapeutics Corp
Memorial Sloan Kettering Cancer Center
MimiVax LLC
Moleculin Biotech Inc
Nino Jesus University Children's Hospital
Novartis AG
Oblato Inc
OncoRx Pharmaceuticals Inc
Oncotelic Therapeutics Inc
Petri Bio LLC
Pfizer Inc
PTC Therapeutics Inc
Pyxis Oncology Inc
Seattle Children's Hospital
Shenzhen Geno-Immune Medical Institute
Shionogi & Co Ltd
SonALASense Inc
Stanford University School of Medicine
Starlight Therapeutics Inc
Stemline Therapeutics Inc
Targepeutics Inc
TCR Cure Biopharma Technology Co Ltd
The Walter and Eliza Hall Institute of Medical Research
University Hospital Antwerp
University of Florida
University of Rochester
Zr Pharma & Gmbh
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Pontine Glioma reports